Bausch + Lomb (BLCO) shares outstanding

Shares outstanding · fiscal 2025
353.80M

Bausch + Lomb (BLCO) had 353.80M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.6% higher than the 351.80M of fiscal 2024. Figures as of 19 Nov 2026, 13:09 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Shares outstanding, fiscal 2025
353.80M
Change on fiscal 2024
+0.6%
Growth, 5 years
+0.2% a year
Highest on record
353.80Mfiscal 2025
Lowest on record
350.00Mfiscal 2020
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Bausch + Lomb shares outstanding, in more detail

The market data feed counts 357.50M shares outstanding today.

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.2% a year. Across the 6 fiscal years on record (2020–2025), the highest was 353.80M in fiscal 2025 and the lowest 350.00M in fiscal 2020.

History · 6 fiscal years

Shares outstanding by fiscal year

Bausch + Lomb shares outstanding, year by year

Bausch + Lomb (BLCO) shares outstanding by fiscal year
Fiscal yearShares outstandingChangeYear ended
2025353.80M 0.6% up
2024351.80M 0.4% up
2023350.50M 0.1% up
2022350.00M 0.0%
2021350.00M 0.0%
2020350.00M—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed.

How to read it

A falling count means buybacks are giving each remaining share a larger slice of the company; a rising one means owners are being diluted.

Shares outstanding at health care companies of similar size

Shares outstanding of Bausch + Lomb and comparable companies
CompanyShares outstandingFiscal year
ImmunityBio IBRX919.86M2025
Cytokinetics CYTK120.10M2025
ABIVAX ABVX69.53M2025
Bausch + Lomb BLCO353.80M2025
Amneal Pharmaceuticals AMRX324.81M2025
Caris Life Sciences CAI167.21M2025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on BLCO

Bausch + Lomb, figure by figure

Bausch + Lomb (BLCO) overview: price, valuation and scorecardAll health care companies by market value

Bausch + Lomb shares outstanding: questions and answers

How many shares does Bausch + Lomb have?

Bausch + Lomb (BLCO) had 353.80M diluted shares on average in fiscal 2025 (the year ended December 31, 2025). That is 0.6% higher than the 351.80M of fiscal 2024. The market data feed counts 357.50M shares outstanding today.

What is the growth rate of Bausch + Lomb's diluted share count?

Over the five fiscal years to 2025 the diluted share count grew at a compound 0.2% a year.

What are the highest and lowest diluted share count figures on record for Bausch + Lomb?

Across the 6 fiscal years on record (2020–2025), the highest was 353.80M in fiscal 2025 and the lowest 350.00M in fiscal 2020.

How is Bausch + Lomb's diluted share count calculated?

The share count for each fiscal year is the diluted weighted average the company reports with its earnings per share, re-based for later stock splits; the number outstanding today comes from the market data feed. For Bausch + Lomb it is on record here for 6 fiscal years, 2020 to 2025.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Bausch + Lomb (BLCO) shares outstanding”, data as of 19 November 2026. https://funkfolio.com/stock/BLCO/shares-outstanding

Underlying data: the company's filings with the SEC and Yahoo Finance.